Annual Meeting 2026
Save the Date - 22 - 25 June 2026
VALIDATE’s 8th Annual Meeting will take place from 22–25 June 2026 in the vibrant city of Cartagena on the Caribbean coast of Colombia.
ECR Workshop - 22 June 2026
The 2026 Annual Meeting will open with a dedicated training day for Early Career Researchers, led by VALIDATE's own Samantha Vermaak and Dr María Adelaida Gómez. This year’s ECR Workshop will focus on grant writing, offering practical guidance on how to turn research ideas into competitive proposals. Through interactive sessions, participants will learn how to identify funding opportunities and structure applications effectively — gaining valuable insights from experienced researchers and grant reviewers.
A Three-Day Annual Meeting - 23 - 25 June 2026
Following the workshop, VALIDATE’s Annual Meeting returns — now extended to three full days to provide even more opportunities for networking, discussion, and collaboration. The meeting is free for VALIDATE members and will showcase cutting-edge vaccine research on our core pathogens: Mycobacteria, Leishmania, and Burkholderia pseudomallei (melioidosis). The expanded format includes talks from international experts, poster sessions, interactive discussions, and social events — an unmissable opportunity to connect with peers and leaders across the global vaccine community.
The Venue- The Hyatt Regecy, Cartagena
Set on Cartagena’s Caribbean coastline, the Hyatt Regency Cartagena offers modern conference facilities, on-site accommodation, and excellent connectivity to the historic walled city. The venue provides an ideal setting for scientific exchange, networking, and collaboration, while also giving delegates the opportunity to experience one of Latin America’s oldest, most vibrant and culturally rich cities.
Your Safety and Travel to Colombia
The VALIDATE Management Team is monitoring international developments as we plan for the 2026 Annual Meeting. Based on current government travel advice, reputable news reporting, and guidance from our Colombian colleagues, we continue to plan for the meeting to take place in Colombia.
We recognise that the situation is complex and may evolve. The safety of our members and delegates remains our highest priority, and we will continue to monitor developments and adapt our plans if necessary, keeping members informed with clear and timely guidance. At this stage, we look forward to delivering a successful meeting in Colombia. If you have any questions, please contact the VALIDATE Team at VALIDATE@ndm.ox.ac.uk.
Register today!
Provisional Agenda
09:00 – 09:30
Registration & tea/coffee
09:30 – 09:35 Welcome
Prof Samantha Sampson — VALIDATE Network Director
09:35 – 09:55 VALIDATE Update
Mrs Samantha Vermaak — Co-Investigator & Executive Manager
09:55 – 10:40 Keynote Talk
10:40 – 11:00 Establishing the immunogenicity of the first naturally presented Leishmania epitope vaccine candidates in Ethiopian cutaneous leishmaniasis
Dr Thao-Thy Pham
11:00 – 11:20 Probing extreme phenotypes to determine correlates of risk for recurrent TB
Dr Happy Tshivhula
11:20 – 11:40 Microbicidal and regulatory functions of bovine neutrophils during Mycobacterium bovis infection
Dr Susana Flores Villalva
11:40 – 11:55 Fellow Q&A Panel
11:55 – 12:55 Lunch
12:55 – 13:25 Investigator Research Talk - TBC
13:25 – 13:45 Determining the metabolic impact of BCG vaccination
Dr Mrinal Das
13:45 – 14:05
Assessing the immunogenicity and protective efficacy of a telomerase-deficient Leishmania major
Dr Mark Shiburah
14:05 – 14:25 Accelerating BCG efficacy: targeting dendritic cell migration
Dr Luciana Balboa
14:25 – 14:40 Q&A Panel
14:40 – 15:10 Afternoon Break
15:10 – 15:40 Investigator Research Talk - TBC
15:40 – 16:55 Networking Session
Chaired by Samantha Vermaak
16:55 – 17:00 Wrap-Up
Sam Sampson
17:00 – 19:00 Poster Session & Drinks Reception
19:00 – 21:30 Annual Meeting Dinner
09:00 – 09:45 Keynote Talk TBC
09:45 – 10:05 Profiling the mycobacterial immune response in human lung tissue to inform novel TB vaccine design
Dr Alba Llibre
10:05 – 10:25 Burden of Burkholderia pseudomallei in Nepal to inform vaccine needs (BURNEP study)
Dr Suraj Bhattarai
10:25 – 10:45 Immune signatures of chronic tuberculosis and cutaneous leishmaniasis
Dr Menberework Negatue
10:45 – 11:00 Q&A Panel
11:00 – 11:30 Break
11:30 – 11:50 Boosting BCG vaccine efficacy through metabolic modulation of T memory stem cells
Dr Mariano Maio
11:50 – 12:10 Measuring the immunogenicity and efficacy of a novel DNA-launched therapeutic for tuberculosis
Dr Robert Krause
12:10 – 12:30 Preclinical evaluation of a recombinant chimeric vaccine for protection against tegumentary leishmaniasis
Dr Camila Freitas
12:30 – 12:45 Fellow Panel Discussion
12:45 – 13:45 Lunch
13:45 – 14:05 Evaluation of a recombinant chimeric protein vaccine with adjuvant for protection against visceral leishmaniasis
Dr Daniela Pagliara Lage
14:05 – 14:25 Defining the mechanism of BCG-priming and its impact on subunit vaccine boosting
Dr Elena Stylianou
14:25 – 14:45 Translating protective immune signatures in the lung to peripheral biomarkers for TB
Dr Paula Niewold
14:45 – 15:00 Activity TBC
15:00 – 15:30 Break
15:30 – 15:45 Innovative Diagnosis for PKDL / Leprosy — Project Update
Prof Mitali Chaterjee
15:45 – 16:05 CCR4LEP: Exploring CCR4 as immune correlate of protection for leprosy
Dr Anouk van Hooij
16:05 – 16:25 Melio MuSe: Multiplex serology advancing multicomponent melioidosis vaccines
Dr Ivo Steinmetz
16:25 – 16:35 Q&A Panel
16:35 – 17:05 Investigator Research Talk TBC
17:05 – 17:10 Wrap up
10:00 – 10:45 Keynote Talk
10:45 – 11:30 Investigator Research Talk TBC
11:30 – 12:00 Break
12:00 – 12:20 Development of versatile and cost-effective next-generation vaccines through multivalent approaches
Dr Julen Tomás Cortázar
12:20 – 12:40 Comparative testing of Ag85 isoforms and consensus sequence optimisation for next-generation TB vaccines
Dr Andy Tran
12:40 – 12:50 Q&A Panel
12:50 – 13:50 Lunch
13:50 – 14:35 Director / Senior Investigator Talk
Dr Maria Adeliada Gomez
14:35 – 14:55 Evaluating the immunogenicity and efficacy of Curdlan-PLGA nanoparticles encapsulating Mycobacterium tuberculosis antigens
Dr Zimvo Obasa
14:55 – 15:15 Pilot study to investigate tissue-based immunological profiles associated with TB using single-cell spatial resolution in human lymph nodes
Dr Monika Looney
15:15 – 15:25 Fellow Panel Discussion
15:25 – 16:10 Activity TBC
16:10 – 16:20 Awards & Closing Remarks
Sam Sampson
VALIDATE offers annual travel grants of up to £3,000 to LMIC members to attend the VALIDATE Annual Meeting (and ECR Workshop, if applicable). To apply, please consult the Annual Meeting Travel Grants guidance document for eligibility and funding details, complete every section of the application form, and submit it with all required documents using the portal below before the deadline of 30 January 2026.
We particularly encourage members from Latin American LMICs to apply for a VALIDATE Travel Grant, to cover their local travel and subsistence costs to join the 2026 Annual Meeting in-person.
Applications will be competitively reviewed by the VALIDATE Network Management Board.
We also invite you to submit a poster abstract for the Annual Meeting, which can strengthen your travel grant application. Further information on poster submissions can be found on the VALIDATE Annual Meeting webpage.
The VALIDATE Annual Meeting 2026 will include keynote talks, research presentations from VALIDATE-funded projects, and networking opportunities, as well as a Poster Session allowing members to showcase important areas of their research and discuss them in person with fellow VALIDATE members from around the world.
To get a sense of what a successful poster abstract looks like, have a look at those presented at the Annual Meeting 2025.
To submit a Poster abstract, please complete the application form and submit it via the portal below by 30 January 2026, after which the VALIDATE Network Management Board will competitively review submissions at their March meeting. Applicants will receive their review outcomes within a week of the board’s decision.
VALIDATE Investigator members are encouraged to apply to present a research talk at the 2026 VALIDATE Annual Meeting.
To submit a Research Talk abstract, please complete the application form by 30 January 2026, ensuring that all stated word limits are followed. Abstracts will be reviewed competitively by the VALIDATE Network Management Board during their March meeting, and applicants will be informed of the results within a week of the Board’s decision.